BIOPHENâ„¢ DiXaI (Direct Xa Inhibitors)
Processing...

BIOPHENâ„¢ DiXaI (Direct Xa Inhibitors)

Code: A221030-CAN
Manufacturer’s Part Number: 221030
Product size: Kit
Clearance: CE / HCL
Price: $420.00
Qty
 

Product Description

In EU: This Product is CE Marked.

Health Canada Licensed.

BIOPHEN™ DiXaI is a two-stage chromogenic assay specifically designed for Direct oral FXa Inhibitors (DOACs) — rivaroxaban (Xarelto®), apixaban (Eliquis®), and edoxaban (Savaysa®/Lixiana®) — in human citrated plasma. ?? NOT for heparins (UFH, LMWH), fondaparinux, or danaparoïd. For heparin monitoring, use BIOPHEN™ Heparin LRT instead. Two-stage method with constant exogenous AT (AT-independent — not affected by patient AT levels). Stage 1: patient DOAC + excess FXa + AT ? DOAC inhibits FXa. Stage 2: residual FXa measured with chromogenic substrate. Calibrators: Rivaroxaban (226001/226101/226201), Apixaban (226401/226501), Edoxaban (222701). Controls: drug-specific control plasmas at standard and low ranges. Dilution buffer: Tris-NaCl-EDTA pH 7.85 (AR032K). CE-IVD.

Product Characteristics

  • Total Assay Time: < 10 min
  • Dynamic Range:
      Standard Range (Rivaroxaban): 0 to 500 ng/mL
      Low Range (Rivaroxaban): 0 to 100 ng/mL
      Standard Range (Apixaban): 0 to 600 ng/mL
      Low Range (Apixaban): 0 to 120 ng/mL
  • Number of Tests (Manual Method): 3 x 10 Tests

Product Components

  • R1: 3 x 2.5 mL purified human FXa, lyophilized.
  • R2: 3 x 2.5 mL FXa chromogenic substrate, lyophilized.
  • R3: 4 x 20 mL Tris-NaCl-EDTA-PEG Buffer, pH 7.85. Ready to use.
  

Product Applications

For the measurement of Rivaroxaban, Apixaban, and other direct Factor Xa inhibitors in research applications.

Please Note: IVD Not for Sale in US. For US availability CLICK HERE.

Instructions For Use

Material Safety Data Sheet (MSDS)

Data Sheet/Technical Data

Certificate of Analysis (COA)

Other Documents

  

Related Products

Code Name Price  
A221030-RUO BIOPHENâ„¢ DiXaI (Direct Xa Inhibitors)    $440.00